1st Quarter - Report

PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) for PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.)

Firm
Client
Income
—
Expenses
$1,320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. ___/S.___, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2025; discussions related to tobacco harm reduction.

LobbyistCovered position, as disclosed
MALLIKA VASTARE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Foreign Relations FOR

Discussions related to U.S. policy guidance provided to executive branch personnel regarding foreign government engagements.

LobbyistCovered position, as disclosed
KEAGAN R LENIHAN —
KELLY LUNGREN MCCOLLUM —
DIEGO ZAMBRANO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

H.R. 1968: Full-Year Continuing Appropriations and Extensions Act, 2025; discussions related to federal excise drawback laws. Discussions related to federal excise tax drawback laws and their application to manufacturing of tobacco products.

LobbyistCovered position, as disclosed
KEAGAN R LENIHAN —
KELLY LUNGREN MCCOLLUM —
KICHELLE WEBSTER TOMLINSON New None

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of

Bills named: H.R. 1968 (119th)

Tobacco TOB

Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products.

LobbyistCovered position, as disclosed
KEAGAN R LENIHAN —
KELLY LUNGREN MCCOLLUM —
MOYER MCCOY —
MALLIKA VASTARE —
KICHELLE WEBSTER TOMLINSON New None
DIEGO ZAMBRANO —

Contacted: SENATE; Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Discussions related to potential tariffs on imported products.

LobbyistCovered position, as disclosed
KELLY LUNGREN MCCOLLUM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Veterans VET

Discussions related to Veterans and health related issues.

LobbyistCovered position, as disclosed
DIEGO ZAMBRANO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
PHILIP MORRIS PRODUCTS S.A. (PARENT COMPANY IS PMI) Switzerland Switzerland — $10,000

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.